Company news
Avalo Therapeutics, Inc. news in 2025
Avalo Therapeutics, Inc.'s news releases, calls and decks from 2025, newest first.
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
November 17, 2025
Avalo Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Updates
November 6, 2025
Avalo Therapeutics Announces Completion of Enrollment in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa
October 29, 2025
Avalo Therapeutics Expands Leadership Team with Key Appointments in Business Development and Human Resources
October 1, 2025
Avalo Therapeutics Appoints Kevin R. Lind to Board of Directors
September 22, 2025
Avalo Reports Second Quarter 2025 Financial Results and Recent Business Updates
August 7, 2025
Avalo Therapeutics Announces Appointment of Rita Jain, M.D. to Board of Directors
June 18, 2025
Avalo Reports First Quarter 2025 Financial Results and Recent Business Updates
May 11, 2025
Avalo Therapeutics to Participate in The Citizens Life Sciences Conference
April 30, 2025
Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board
March 26, 2025
Avalo Reports 2024 Financial Results and Recent Business Updates
March 20, 2025
Avalo Therapeutics Appoints Jennifer Riley as Chief Strategy Officer
January 1, 2025
Decks in 2025
- Investor Presentation (December 2025)
Investor deck · 21 slides · Dec 2, 2025
- Investor Presentation (October 2025)
Investor deck · 21 slides · Oct 10, 2025
- Investor Presentation (June 2025)
Investor deck · 21 slides · Jun 20, 2025
- Investor Presentation (June 2025)
Investor deck · 24 slides · Jun 4, 2025
- Investor Presentation (May 2025)
Investor deck · 24 slides · May 8, 2025
- Investor Presentation (January 2025)
Investor deck · 24 slides · Jan 13, 2025